Viimeisimmät kokeilut


EudraCT Number: 2022-001811-16 Sponsor Protocol Number: PS21GAP Start Date:
Sponsor Name: Princess Maxima Center for pediatric oncology
Full Title: 68Ga-SATO in pediatric neuroblastoma patient; exploratory, safety, non-randomized, open label, comparative study
Medical condition: Neuroblastoma
Disease: Version SOC Term Classification Code Term Level
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10029260 Neuroblastoma PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-002965-38 Sponsor Protocol Number: 004 Start Date:
Sponsor Name: Chirurgische Gemeinschaftspraxis Südstadt
Full Title: Comparison of sclerotherapy for first grade haemorrhoids using Aethoxylsklerol foam versus fluid: A randomised, controlled, multicentre, single blinded trial.
Medical condition: Bleeding first-grade haemorrhoids
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2008-007845-29 Sponsor Protocol Number: P07-07 / BF 2.649 Start Date:
Sponsor Name: Bioprojet
Full Title: Prospective, randomized, double-blind study, parallel-group, multi-center trial assessing the effects of escalating doses of BF2.649 and BF2.649 add on Modafinil on cataplexy in patients with narco...
Medical condition: Cataplexy in patients with narcolepsy
Disease: Version SOC Term Classification Code Term Level
9.1 10028713 Narcolepsy LLT
9.1 10048322 Narcolepsy aggravated LLT
9.1 10021235 Idiopathic narcolepsy LLT
9.1 10007737 Cataplexy LLT
9.1 10048323 Cataplexy aggravated LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) HU (Completed) FR (Completed) NL (Completed)
Trial results: View results

EudraCT Number: 2011-001033-16 Sponsor Protocol Number: NN7008-3809 Start Date:
Sponsor Name: Novo Nordisk A/S
Full Title: Safety and Efficacy of NNC 0155-0000-0004 in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients with Haemophilia A
Medical condition: Haemophilia A
Disease: Version SOC Term Classification Code Term Level
14.0 10010331 - Congenital, familial and genetic disorders 10018937 Haemophilia A LLT
Population Age: Newborns, Infants and toddlers, Children, Under 18 Gender: Male
Trial protocol: GB (Prematurely Ended) AT (Completed) ES (Completed) GR (Completed) DK (Completed) HU (Completed) LT (Completed) PL (Completed) PT (Completed)
Trial results: View results
EudraCT Number: 2006-002567-62 Sponsor Protocol Number: CK-LX3401 Start Date:
Sponsor Name: Cardiokine Biopharma, LLC
Full Title: THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
Medical condition: Hyponatremia
Disease: Version SOC Term Classification Code Term Level
9.1 10021038 Hyponatremia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) IT (Completed) CZ (Completed) SK (Completed) ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2019-000560-22 Sponsor Protocol Number: MT-12 Start Date:
Sponsor Name: ALK-Abelló A/S
Full Title: A one-year placebo-controlled phase III trial evaluating the efficacy and safety of the house dust mite (HDM) SLIT-tablet in children (5-11 years of age) with HDM allergic rhinitis/rhinoconjunctivi...
Medical condition: Allergic rhinitis/rhinoconjunctivitis induced by house dust mites
Disease: Version SOC Term Classification Code Term Level
20.0 100000004870 10020419 House dust mite allergy LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: FR (Completed) SK (Completed) DE (Completed) PL (Completed) ES (Ongoing) BG (Completed) LT (Completed)
Trial results: View results
EudraCT Number: 2021-005493-25 Sponsor Protocol Number: EFISS Start Date:
Sponsor Name: Fakultní nemocnice Brno
Full Title: Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery: A randomized pilot study (EFISS trial)
Medical condition: Scoliosis
Disease: Version SOC Term Classification Code Term Level
20.0 10042613 - Surgical and medical procedures 10039727 Scoliosis surgery PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: (No results available)

EudraCT Number: 2021-006903-14 Sponsor Protocol Number: ARQ-151-315 Start Date:
Sponsor Name: Arcutis Biotherapeutics, Inc.
Full Title: A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.05% Administered QD in Subjects with Atopic Dermatitis
Medical condition: Atopic Dermatitis
Disease: Version SOC Term Classification Code Term Level
21.1 100000004858 10003639 Atopic dermatitis LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2022-002384-30 Sponsor Protocol Number: ABR81872 Start Date:
Sponsor Name: Erasmus MC - Sophia
Full Title: Reduction of blood loss in pediatric osteotomies around the hip - A randomized placebo-controlled trial with tranexamic acid –
Medical condition: Osteotomies around the hip, i.e. proximal femoral and/or pelvic osteotomies (PFPO) in children, for e.g: - hip dysplasia - secondary hip dysplasia - hip incongruenties due to other problems (e.g. p...
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-005891-41 Sponsor Protocol Number: 109509 Start Date:
Sponsor Name: GlaxoSmithKline Biologicals
Full Title: A phase IIIb, observer-blind, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar whe...
Medical condition: Booster vaccination against Streptococcus pneumoniae or Haemophilus influenzae in healthy infants 12 to 18 months of age who were previously primed with three doses of pneumococcal conjugate vaccin...
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: PL (Ongoing)
Trial results: View results
3